TTNP
TITAN PHARMACEUTICALS INCCompany Information
- Company Name
- TITAN PHARMACEUTICALS INC
- CIK
- CIK0000910267
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- TTNP: None
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- TTNP
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-01-25
- Last sale
- 2023-06-21
- Shares purchased (TTM)
- 764,294
- Shares sold (TTM)
- 3,388,902
Institutional Sentiment
- As of
- 2025-09-30
- Institutional shares owned
- 22,360
- Shares outstanding
- 1,065,000
- Ownership
- 2.10%
Earnings Market Reaction
- Filing date
- —
- Price on filing date
- —
- 1-month reaction
- —
- 3-month reaction
- —
Balance Sheet
Values in millions ($)| Line item | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 3 | 2 | 3 | 3 | 4 | 6 | 7 | 8 | 0 | 1 | 3 | 4 | ||||||
| Restricted Cash | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Receivables Net Current | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Accounts Receivable Net Current | - | - | - | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Accounts And Notes Receivable Net | - | - | - | - | - | - | 1 | 2 | - | - | - | - | ||||||
| Inventory Net | - | - | - | - | - | - | 0 | - | - | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Assets Current | 3 | 2 | 3 | 4 | 4 | 7 | 8 | 10 | 0 | 2 | 4 | 6 | ||||||
| Property Plant And Equipment Net | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Assets | 3 | 2 | 3 | 4 | 4 | 7 | 8 | 10 | 1 | 2 | 4 | 6 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Other Accrued Liabilities Current | 0 | 0 | 0 | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Liabilities | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | ||||||
Stockholders Equity | ||||||||||||||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 401 | 399 | 399 | 399 | 399 | 399 | 398 | 398 | 388 | 388 | 388 | 387 | ||||||
| Retained Earnings Accumulated Deficit | -398 | -397 | -397 | -396 | -395 | -393 | -392 | -390 | -390 | -388 | -386 | -384 | ||||||
| Stockholders Equity | 3 | 2 | 2 | 3 | 4 | 6 | 7 | 8 | -1 | -0 | 1 | 4 | ||||||
| Liabilities And Stockholders Equity | 3 | 2 | 3 | 4 | 4 | 7 | 8 | 10 | 1 | 2 | 4 | 6 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | - | - | 5 | - | ||||||
| Preferred Stock Shares Issued | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 225 | 225 | 225 | 225 | 225 | 225 | 225 | 225 | 225 | 225 | 225 | 225 | ||||||
| Common Stock Shares Issued | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | ||||||
| Shares Outstanding | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTITAN PHARMACEUTICALS INC (TTNP) — SEC Financial Statements & Analysis
TITAN PHARMACEUTICALS INC (TTNP) is a biological products, (no diagnostic substances) company, incorporated in DE. TITAN PHARMACEUTICALS INC trades on None as: TTNP. TITAN PHARMACEUTICALS INC (TTNP)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-14. Based on that filing, On profitability, TITAN PHARMACEUTICALS INC posts an operating margin of 582200.00%, a net margin of 588600.00%, a Return on Equity (ROE) of -82.72%, and a Return on Assets (ROA) of -75.80%. Per share, it reports EPS of $-2.63, diluted EPS of $-2.63, free cash flow per share of $-2.58, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -48.64% year-over-year, and EPS growth of -55.92% year-over-year. On the balance sheet, it maintains a current ratio of 11.60x, a quick ratio of 11.20x, working capital of $2.79M, a debt-to-equity ratio of 0.09x, a debt ratio of 0.09, an interest coverage ratio of -4557.00x, free cash flow of $-2.75M (TTM), and net debt of $-2.80M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-2.63
- ROE TTM
- -82.72%
- ROA TTM
- -75.80%
- Debt To Equity
- 0.09x
- Free Cash Flow TTM
- $-2.75M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2025-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is TITAN PHARMACEUTICALS INC in?
TITAN PHARMACEUTICALS INC (TTNP) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does TTNP trade on?
TITAN PHARMACEUTICALS INC (TTNP) trades on the None.
Where is TITAN PHARMACEUTICALS INC incorporated?
TITAN PHARMACEUTICALS INC is incorporated in DE.
When was TITAN PHARMACEUTICALS INC (TTNP)'s most recent SEC filing?
TITAN PHARMACEUTICALS INC (TTNP)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-14.
What is TTNP's EPS (earnings per share)?
TITAN PHARMACEUTICALS INC (TTNP)'s trailing twelve month EPS is $-2.63 as of 2025-06-30.
What is TTNP's ROE (return on equity)?
TITAN PHARMACEUTICALS INC (TTNP)'s trailing twelve month Return on Equity (ROE) is -82.72% as of 2025-06-30.
What is TTNP's ROA (return on assets)?
TITAN PHARMACEUTICALS INC (TTNP)'s trailing twelve month Return on Assets (ROA) is -75.80% as of 2025-06-30.